Elsevier,
Geography and Sustainability, Volume 3, Issue 4, December 2022, Pages 347-357
This article supports SDG 13 by demonstrating the climate change mitigation potential of different land-based options and highlighting the importance of analyzing their implications for biodiversity and other ecosystem services to support the design of solutions that can co-deliver for multiple challenges.
Elsevier, Neuropharmacology, Volume 218, 1 November 2022
This aritcle ties to SDG 3. This review is focused on the most widely used drugs for the pharmacological treatment of PTSD with a translational approach, including clinical and preclinical studies, to emphasize the need to develop safer and more effective medications.
Elsevier,
Annals of Hepatology, Volume 27, 1 November 2022
This article aligns with the SDG goal 3 of Good health and wellbeing and SDG 10 Reduced inequalities by highlighting the importance of hepatitis C virus testing among high-risk population groups such as people living with HIV and intravenous drug users.
Elsevier, The Lancet Regional Health - Europe, Volume 22, November 2022
This Article supports SDGs 3 and 10, examining the mortality risk for people aged 25-44 years with disability, and shows that the risk increases with different types and severities of disability and is particiularly associated with mental health problems and motor impairment
Elsevier,
American Journal of Clinical Nutrition, Volume 116, 1 November 2022
The positive association of choline for cognition has been reported in both animal and human studies, yet the associations of choline with the risks of incident dementia or Alzheimer’s disease (AD) in humans is unclear and the objective of this paper was to test the hypothesis that lower or higher dietary choline intake is associated with increased or decreased, respectively, risks of incident dementia and AD. The paper concludes that low dietary choline intake was associated with increased risks of incident dementia and AD and that further investigations regarding the effects of high choline intake on dementia and AD risks are warranted.
